Shin J, Hong S, Kim M, Lee H, Choi H, Kim J
Hum Gene Ther. 2020; 32(9-10):517-527.
PMID: 32854548
PMC: 8140350.
DOI: 10.1089/hum.2020.050.
Cotter C, Moss B
J Virol. 2020; 94(10).
PMID: 32132239
PMC: 7199393.
DOI: 10.1128/JVI.00077-20.
Hong G, Tsai C, Chang W
J Virol. 2020; 94(10).
PMID: 32132237
PMC: 7199405.
DOI: 10.1128/JVI.00093-20.
Monticelli S, Earley A, Tate J, Ward B
J Virol. 2018; 93(4).
PMID: 30463966
PMC: 6364035.
DOI: 10.1128/JVI.01343-18.
Sobhy H
Arch Virol. 2017; 162(12):3567-3585.
PMID: 28866775
PMC: 5671522.
DOI: 10.1007/s00705-017-3497-8.
Protein Primary Structure of the Vaccinia Virion at Increased Resolution.
Ngo T, Mirzakhanyan Y, Moussatche N, Gershon P
J Virol. 2016; 90(21):9905-9919.
PMID: 27558425
PMC: 5068539.
DOI: 10.1128/JVI.01042-16.
Membrane fusion during poxvirus entry.
Moss B
Semin Cell Dev Biol. 2016; 60:89-96.
PMID: 27423915
PMC: 5161597.
DOI: 10.1016/j.semcdb.2016.07.015.
Evolution of and evolutionary relationships between extant vaccinia virus strains.
Qin L, Favis N, Famulski J, Evans D
J Virol. 2014; 89(3):1809-24.
PMID: 25410873
PMC: 4300770.
DOI: 10.1128/JVI.02797-14.
A novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranes.
Laliberte J, Moss B
J Virol. 2014; 88(17):9751-68.
PMID: 24920806
PMC: 4136360.
DOI: 10.1128/JVI.00816-14.
Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein.
Breiman A, Carpentier D, Ewles H, Smith G
J Gen Virol. 2012; 94(Pt 4):720-725.
PMID: 23255618
PMC: 3709683.
DOI: 10.1099/vir.0.049486-0.
Poxvirus cell entry: how many proteins does it take?.
Moss B
Viruses. 2012; 4(5):688-707.
PMID: 22754644
PMC: 3386626.
DOI: 10.3390/v4050688.
Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production.
Chan W, Ward B
J Virol. 2012; 86(15):8232-44.
PMID: 22623782
PMC: 3421646.
DOI: 10.1128/JVI.00253-12.
The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains.
Chan W, Ward B
J Virol. 2012; 86(15):8210-20.
PMID: 22623777
PMC: 3421693.
DOI: 10.1128/JVI.00249-12.
Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions.
Doceul V, Hollinshead M, Breiman A, Laval K, Smith G
J Gen Virol. 2012; 93(Pt 9):1876-1886.
PMID: 22622330
PMC: 3709573.
DOI: 10.1099/vir.0.043943-0.
Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.
Jarahian M, Fiedler M, Cohnen A, Djandji D, Hammerling G, Gati C
PLoS Pathog. 2011; 7(8):e1002195.
PMID: 21901096
PMC: 3161980.
DOI: 10.1371/journal.ppat.1002195.
The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.
DeHaven B, Gupta K, Isaacs S
J Gen Virol. 2011; 92(Pt 9):1971-1980.
PMID: 21715594
PMC: 3353385.
DOI: 10.1099/vir.0.030460-0.
Smallpox vaccines: targets of protective immunity.
Moss B
Immunol Rev. 2011; 239(1):8-26.
PMID: 21198662
PMC: 3074351.
DOI: 10.1111/j.1600-065X.2010.00975.x.
Poxvirus complement control proteins are expressed on the cell surface through an intermolecular disulfide bridge with the viral A56 protein.
DeHaven B, Girgis N, Xiao Y, Hudson P, Olson V, Damon I
J Virol. 2010; 84(21):11245-54.
PMID: 20719953
PMC: 2953161.
DOI: 10.1128/JVI.00372-10.
Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein.
Breiman A, Smith G
J Gen Virol. 2010; 91(Pt 7):1823-7.
PMID: 20200189
PMC: 3052527.
DOI: 10.1099/vir.0.020677-0.
Poxvirus proteomics and virus-host protein interactions.
Van Vliet K, Mohamed M, Zhang L, Villa N, Werden S, Liu J
Microbiol Mol Biol Rev. 2009; 73(4):730-49.
PMID: 19946139
PMC: 2786582.
DOI: 10.1128/MMBR.00026-09.